REFERENCES
1. Pritchard J, Brown J, Shafford E,
et al. Cisplatin, doxorubicin, and delayed surgery for childhood
hepatoblastoma: a successful approach–results of the first
prospective study of the International Society of Pediatric Oncology.J Clin Oncol . Nov 15 2000;18(22):3819-28.
doi:10.1200/JCO.2000.18.22.3819
2. Ramos-Gonzalez G, LaQuaglia M,
O’Neill AF, et al. Long-term outcomes of liver transplantation for
hepatoblastoma: A single-center 14-year experience. Pediatr
Transplant . Jun 11 2018:e13250. doi:10.1111/petr.13250
3. Kasahara M, Ueda M, Haga H, et al.
Living-donor liver transplantation for hepatoblastoma. Am J
Transplant . Sep 2005;5(9):2229-35. doi:10.1111/j.1600-6143.2005.01003.x
4. Sakamoto S, Kasahara M, Mizuta K,
et al. Nationwide survey of the outcomes of living donor liver
transplantation for hepatoblastoma in Japan. Liver Transpl . Mar
2014;20(3):333-46. doi:10.1002/lt.23803
5. Kueht M, Thompson P, Rana A, Cotton
R, O’Mahony C, Goss J. Effects of an early referral system on liver
transplantation for hepatoblastoma at Texas Children’s Hospital.Pediatr Transplant . Jun 2016;20(4):515-22. doi:10.1111/petr.12699
6. Umeda K, Okajima H, Kawaguchi K, et
al. Prognostic and therapeutic factors influencing the clinical outcome
of hepatoblastoma after liver transplantation: A single-institute
experience. Pediatr Transplant . Mar
2018;22(2)doi:10.1111/petr.13113
7. Pimpalwar AP, Sharif K, Ramani P,
et al. Strategy for hepatoblastoma management: Transplant versus
nontransplant surgery. J Pediatr Surg . Feb 2002;37(2):240-5.
doi:10.1053/jpsu.2002.30264
8. Meyers RL, Tiao G, de Ville de
Goyet J, Superina R, Aronson DC. Hepatoblastoma state of the art:
pre-treatment extent of disease, surgical resection guidelines and the
role of liver transplantation. Curr Opin Pediatr . Feb
2014;26(1):29-36. doi:10.1097/MOP.0000000000000042
9. Neto JS, Pugliese R, Fonseca EA, et
al. Four hundred thirty consecutive pediatric living donor liver
transplants: variables associated with posttransplant patient and graft
survival. Liver Transpl . May 2012;18(5):577-84.
doi:10.1002/lt.23393
10. Neto JS, Carone E, Pugliese V, et
al. Living donor liver transplantation for children in Brazil weighing
less than 10 kilograms. Liver Transpl . Aug 2007;13(8):1153-8.
doi:10.1002/lt.21206
11. Brown J, Perilongo G, Shafford E,
et al. Pretreatment prognostic factors for children with
hepatoblastoma– results from the International Society of Paediatric
Oncology (SIOP) study SIOPEL 1. Eur J Cancer . Jul
2000;36(11):1418-25. doi:10.1016/s0959-8049(00)00074-5
12. Malogolowkin MH, Katzenstein HM,
Krailo M, Meyers RL. Treatment of hepatoblastoma: the North American
cooperative group experience. Front Biosci (Elite Ed) . Jan 1
2012;4:1717-23. doi:10.2741/492
13. Otte JB, Pritchard J, Aronson DC,
et al. Liver transplantation for hepatoblastoma: results from the
International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and
review of the world experience. Pediatr Blood Cancer . Jan
2004;42(1):74-83. doi:10.1002/pbc.10376
14. Meyers RL, Czauderna P, Otte JB.
Surgical treatment of hepatoblastoma. Pediatr Blood Cancer . Nov
2012;59(5):800-8. doi:10.1002/pbc.24220
15. Otte JB. Progress in the surgical
treatment of malignant liver tumors in children. Cancer Treat
Rev . Jun 2010;36(4):360-71. doi:10.1016/j.ctrv.2010.02.013
16. Czauderna P, Haeberle B, Hiyama
E, et al. The Children’s Hepatic tumors International Collaboration
(CHIC): Novel global rare tumor database yields new prognostic factors
in hepatoblastoma and becomes a research model. Eur J Cancer . Jan
2016;52:92-101. doi:10.1016/j.ejca.2015.09.023
17. Browne M, Sher D, Grant D, et al.
Survival after liver transplantation for hepatoblastoma: a 2-center
experience. J Pediatr Surg . Nov 2008;43(11):1973-81.
doi:10.1016/j.jpedsurg.2008.05.031
18. Isono K, Ohya Y, Lee KJ, et al.
Pretransplant trends in alpha-fetoprotein levels as a predictor of
recurrence after living donor liver transplantation for unresectable
hepatoblastoma: A single-institution experience. Pediatr
Transplant . Aug 2018;22(5):e13221. doi:10.1111/petr.13221
19. Lauferman L, Halac E, Aredes D,
et al. Prognostic factors for event-free survival in liver
transplantation for hepatoblastoma: A single-center experience.Pediatr Transplant . Dec 2019;23(8):e13581. doi:10.1111/petr.13581
20. Avila LF, Encinas JL, Leal N, et
al. [Liver transplatation for malignant tumors in children].Cir Pediatr . Oct 2007;20(4):189-93. Trasplante hepatico en
tumores malignos en el nino.
21. Casas-Melley AT, Malatack J,
Consolini D, et al. Successful liver transplant for unresectable
hepatoblastoma. J Pediatr Surg . Jan 2007;42(1):184-7.
doi:10.1016/j.jpedsurg.2006.09.017
22. Otte JB, de Ville de Goyet J. The
contribution of transplantation to the treatment of liver tumors in
children. Semin Pediatr Surg . Nov 2005;14(4):233-8.
doi:10.1053/j.sempedsurg.2005.06.006
23. De Ioris M, Brugieres L,
Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein
level at diagnosis: the SIOPEL group experience. Eur J Cancer .
Mar 2008;44(4):545-50. doi:10.1016/j.ejca.2007.11.022
24. Marin JJG, Cives-Losada C,
Asensio M, Lozano E, Briz O, Macias RIR. Mechanisms of Anticancer Drug
Resistance in Hepatoblastoma. Cancers (Basel) . Mar 22
2019;11(3)doi:10.3390/cancers11030407
25. Candido HL, da Fonseca EA, Feier
FH, et al. Risk Factors Associated with Increased Morbidity in Living
Liver Donation. J Transplant . 2015;2015:949674.
doi:10.1155/2015/949674
26. Trotter JF, Adam R, Lo CM,
Kenison J. Documented deaths of hepatic lobe donors for living donor
liver transplantation. Liver Transpl . Oct 2006;12(10):1485-8.
doi:10.1002/lt.20875
27. Reyes JD, Carr B, Dvorchik I, et
al. Liver transplantation and chemotherapy for hepatoblastoma and
hepatocellular cancer in childhood and adolescence. J Pediatr .
Jun 2000;136(6):795-804.
28. von Schweinitz D, Wischmeyer P,
Leuschner I, et al. Clinico-pathological criteria with prognostic
relevance in hepatoblastoma. Eur J Cancer . 1994;30A(8):1052-8.
doi:10.1016/0959-8049(94)90454-5
29. Okur MH, Yankol Y, Cimsit B, et
al. Liver Transplant in Children with Hepatoblastoma. Exp Clin
Transplant . Oct 2019;17(5):644-647. doi:10.6002/ect.2016.0110